PET/CT

News • Interstital lung disease

Lung cancer: PET/CT imaging analysis with AI predicts immunotherapy side effects

PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, a serious side effect of immunotherapy in lung cancer, a new study shows.

Celebrating molecular imaging milestones across Europe

United Imaging launches the uMI Panvivo, the uMI Panorama GS and Nuclear Medicine AI Solution at EANM, and announces strategic partnerships, reinforcing its commitment to advancing molecular imaging…

News • Insulinoma imaging

New PET technique reveals rare pancreas tumors

Insulinomas are benign tumors in the pancreas, but can still cause problems for patients. A new imaging technique reliably detects these previously hard-to-find tumors, according to recent research.

News • Neuroblastoma diagnosis without anaesthesia

New PET/CT technique improves brain tumour detection in children

To diagnose neuroblastoma in children, lengthy scans and anaesthesia are often required. A new PET/CT imaging technique could deliver faster results without sedation for the paediatric patients.

Entering the French market with advanced PET/CT imaging

United Imaging, a company specializing in advanced imaging solutions, is proud to announce the first installment of their cutting-edge technology in France. The increasing number of healthcare…

uMI 550 – a new era in mobile PET/CT imaging

United Imaging is pleased to announce the installation of their uMI 550 mobile system in Germany. Starting in September, Alliance Medical Northern Europe (part of the Alliance Medical Group) is using…

Brand-new nuclear medicine department equipped with advanced Total-Body PET/CT system

The new Nuclear Medicine Department of the San Pietro Fatebenefratelli Hospital was inaugurated in Rome. The Department was inaugurated with the online intervention of Health Minister Orazio Schillaci and in the presence of Maria Tripodi (Undersecretary at the Ministry of Foreign Affairs and International Cooperation), Antonello Aurigemma (President of Lazio Regional Council).

News • Specific TB scan

PET imaging shows tuberculosis in the body

A new radiotracer enables positron emission tomography (PET) scans to be used for the first time to accurately pinpoint when and where tuberculosis (TB) is still active in a patient’s lungs.

World's First Total-Body PET/CT with 194 cm Axial FOV installed in Europe

The IRCCS in Bologna has inaugurated a state-of-the-art integrated PET/CT system. This cutting-edge technology allows for the entire human body to be studied in a single scan, even detecting the smallest tumour cells.

News • Clear cell renal cell cancer

Same-day imaging for ccRCC kidney cancer with new PET agent

A new study suggests superiority of the novel investigational PET imaging agent ⁶⁸Ga-DPI-4452 (Debio 0328) to standard CT imaging in the context of clear cell renal cell cancer (ccRCC).

News • Noninvasive stratification

Multiplex PET helps doctors 'see' bowel cancer

Multiplex PET imaging technology could provide a ground-breaking new approach for diagnosing and treating bowel cancer patients, according to scientists in Glasgow.

News • Accurate detection and removal

Radioguided surgery to treat metastatic lymph nodes in prostate cancer

Dutch researchers use PSMA targeting to improve detection of prostate cancer, improving nodal staging and guiding more accurate surgery for this important patient population.

Bringing mobile PET/CT to Italy

United Imaging Healthcare Europe, a leading company in advanced medical imaging and radiotherapy equipment, proudly announces the introduction of its first Mobile Digital PET/CT solution in Italy, now fully operational in the Piacenza province under the auspices of the Azienda Unità Sanitaria Locale Piacenza (AUSLP) hospital.

News • New imaging agent

HER2-positive breast cancer: Whole-body PET/CT predicts targeted therapy response

A new imaging agent can predict early metabolic response to HER2-targeted treatment in metastatic breast cancer patients, according to new research published in the Journal of Nuclear Medicine.

News • Brain imaging

Tau-PET: a window into the future of Alzheimer’s patients

A team from Geneva demonstrates the value of imaging to detect the presence of tau protein in the brain to predict cognitive decline due to Alzheimer’s disease.

News • Nuclear imaging marker

Renal cell carcinoma: New radiotracer improves detection and differentiation

A new PET tracer, 89Zr-DFO-girentuximab, can accurately detect a type of kidney cancer called clear cell renal cell carcinoma and differentiate it from other types of kidney tumors.

News • Folate receptor exploitation

PET imaging: new discovery to help detect brain tumours

Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to detect folate receptors in brain tumours, researchers from the University of Turku report.

News • PSMA-PET/CT

Advanced imaging may help in clinical treatment of prostate cancer

An advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a clearer view of suspected tumours during biopsy.

News • Nuclear imaging

New PET radiotracer to reduce false-positive cancer findings after Covid-19 vaccination

A novel imaging agent can reduce the number of false-positive PET/CT findings among cancer patients recently vaccinated for Covid-19. This may mitigate the issue of tracer uptake in lymph nodes associaed with the vaccine.

Article • Image augmentation, interpretation and evaluation

AI in multimodality hybrid imaging: a diamond in the rough

AI-based models for multimodality hybrid imaging have the potential to be a potent clinical tool but are currently held back by a lack of transparency and maturity, says Dr Irène Buvat, from the Laboratory of translational Imaging in Oncology, Institute Curie in Paris, France.

News • T cell visualization

Whole body scan shows complexity of immunotherapy response

Dutch scientists have performed whole-body PET scans using a radioactively labeled antibody tracer against immune cells, to predict the effect of treatment with immune checkpoint inhibitors.

Article • Mid-treatment scans can reduce treatment sessions

De-escalating radiation therapy for oropharynx cancer with FDG-PET

Using fluorodeoxyglucose positron emission tomography (FDG-PET) imaging may give insights into possible dose reductions in ongoing radiation therapy of head and neck cancer. A promising study to explore this option was presented at the 2022 ASTRO/ASCO Multidisciplinary Head and Cancer Symposium held in Phoenix, Arizona.

News • Neurological disease marker

Promising new radiotracer for demyelination

US researchers have developed a test to detect loss of myelin - a key contributor to many neurological diseases including multiple sclerosis, traumatic brain and spinal cord injuries, stroke, and dementia.

Article • Ovarian cancer and endometriosis detection

Women’s health imaging: PET/CT and T2*w MR show promise

Diagnostic imaging in women’s health advances: PET/CT might provide a more accurate imaging alternative to CT in ovarian cancer. T2*-weighted MR imaging in deep endometriosis detection also shows promise, but ultimately falls flat.

News • Abdominal aortic aneurysm

Novel radiotracer shows promise to predict AAA rupture

A new positron emission tomography (PET) radiotracer can detect abdominal aortic aneurysms (AAAs) and potentially predict when they will rupture, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. Targeting a novel biomarker associated with AAA, the radiotracer is effective both in diagnosis and in providing information to assist in the…

142 show more articles